Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales139 367153 290177 526184 098192 779203 448
EBITDA10 60411 90813 05312 64213 08813 673
Operating profit (EBIT)9 19110 42711 37310 05310 58410 994
Pre-Tax Profit (EBT)------
Net income4 6445 2375 3175 3045 7866 155
P/E ratio24,321,116,115,713,412,1
EPS ( $ )3,964,634,905,045,896,52
Dividend per Share ( $ )1,101,401,701,972,242,66
Yield1,14%1,43%2,15%2,50%2,84%3,37%
Reference price ( $ )96.3197.7778.9178.8978.8978.89
Announcement Date02/10/2015
12:00pm
02/09/2016
11:51am
02/09/2017
11:55am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt10 44024 91724 07324 74424 89224 827
Finance------
Operating income (EBITDA)10 60411 90813 05312 64213 08813 673
Leverage
(Debt/EBITDA)
0,98x2,09x1,84x1,96x1,90x1,82x
Capital Expenditure2 1362 3672 2242 1862 2662 224
Book Value Per Share (BVPS)33,3 $33,8 $34,7 $35,0 $35,9 $37,0 $
Cash Flow per Share6,96 $7,47 $9,33 $8,91 $9,72 $11,0 $
Announcement Date02/10/2015
12:00pm
02/09/2016
11:51am
02/09/2017
11:55am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 80 197 M$ -
Entreprise Value (EV) 104 941 M$ 105 089 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 15,7x 13,4x
Capitalization / Revenue 0,44x 0,42x
EV / Revenue 0,57x 0,55x
EV / EBITDA 8,30x 8,03x
Yield (DPS / Price) 2,50% 2,84%
Price to book (Price / BVPS) 2,25x 2,20x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 5,46% 5,49%
operating Leverage (Delta EBIT / Delta Sales) - 1,12x
Net Margin (Net Profit / Revenue) 2,88% 3,00%
ROA (Net Profit / Asset) 7,37% 7,84%
ROE (Net Profit / Equities) 15,6% 17,0%
Rate of Dividend 39,2% 38,0%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   1,19% 1,18%
Cash Flow / Sales 4,92% 5,12%
Capital Intensity (Assets / Sales) 0,39x 0,38x
Financial Leverage (Net Debt / EBITDA) 1,96x 1,90x
EPS & Dividend